Why Prioritizing Patients Changes How Study Teams Approach DHTs

Although technology provides vast opportunities to improve clinical trial efficiency and unlock new...

Validating Wearable Technology for ALS Research | DEAR Grant Profile

The development of new drugs for rare diseases is hampered by the lack of precise and reliable...

ActiGraph's Reimagined Logo, Website, and Mission Statement

At ActiGraph, we're proud of our history of partnering with clinical researchers around the world,...

Improving Sleep Assessment in Down Syndrome Research | DEAR Grant Profile

Sleep is a crucial aspect of health and quality of life, and disturbed or impaired sleep can be...

Position Your DHT Innovation for Success

Clinical trialists today can benefit from the many hard lessons learned over the last 10 years....

Accelerate Clinical Development with Patient-Centric Digital Endpoints

Drug development success rates have been on the decline since 2015. Compounded by the pandemic,...

ActiGraph DHT Platform Upgrade for Agile and Robust Algorithm Implementation

Digital transformation in healthcare and clinical research has been slower to progress than in...

Bridging the Knowledge Gap on Digital Clinical Measures: A Technology Partner’s Perspective on ‘The Playbook’

ActiGraph was one of the very first commercial providers of wearable motion-sensing technology,...

More Sensors. More Data. Unparalleled Performance.

Here at ActiGraph, we’re a bit obsessed with data and data quality. Because our CentrePoint®...

Why is Oncology Drug Development Research Late to the Digital Biomarkers Game?

During the recent Annual ASCO Meeting, thousands of cancer researchers and clinicians from across...